SecBot SecBot
144 ·Filed Jun 30, 2026

KYMR

Kymera Therapeutics, Inc.
BEARISH
Impact 4/10
Horizondays Processed4mo ago SEC0001950047-26-006647
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for subsequent Form 4 filings to confirm execution of the sale. The filing extends a recent insider selling pattern, which may signal reduced conviction at current valuation levels. Given the company's high analyst bullish consensus (93%), the selling could create short-term overhang.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$114.20
T+0 close · Jun 30, 2026 · via day close
Latest settled
+1.41%
T+60 · $115.81
Vs SPY
−1.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 1 $114.20entry
  2. T+1 · 5mo ago −0.60%α −0.47% · $113.51
  3. T+5 · 4mo ago +4.41%α +4.15% · $119.24
  4. T+20 · 4mo ago −7.84%α −5.65% · $105.25
  5. T+60 · 8w ago +1.41%α −1.55% · $115.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Officer Bruce N. Jacobs filed a Form 144 notice of intent to sell 77,109 shares of Kymera Therapeutics common stock, with an estimated aggregate market value of approximately $8.4 million. The shares derive from stock option exercises and restricted stock unit vesting, and the filing adds to a pattern of recent insider selling totaling $10.0M over the past 30 days.

Key Facts

  • Bruce N. Jacobs, an officer of Kymera Therapeutics, filed Form 144 on 06/30/2026 indicating intent to sell 77,109 shares.
  • Estimated aggregate market value of the proposed sale is $8,429,555.88 based on the filing date.
  • Shares to be sold consist of 61,378 from stock option exercises and 15,731 from restricted stock unit vesting.
  • Recent insider activity shows 7 sells totaling $10.0M in the last 30 days, adding to this selling trend.

Financial Impact

Proposed sale of ~$8.4M in shares, representing approximately 0.09% of Kymera's $9.4B market cap.

dilutioninsider holdings

Risk Factors

  • Insider selling may indicate a lack of confidence in near-term prospects or a desire to diversify.
  • Additional insider sales could follow, increasing supply and weighing on the stock.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006647
Document: 0001950047-26-006647-index.html0001950047-26-006647
Document: 0001950047-26-006647.txt0001950047-26-006647

Track record

37 reports on KYMR

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 8 of 13 went positive at some point.

Filters
  1. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
  2. Oct 29, 202618d ago 8-K Neutral 5/10 No price data
  3. Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
  4. Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
  5. Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
  6. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
  8. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
  9. Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
Showing 10 of 37

US Market Status

Market Closed · Opens in 8h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026